ALK and lymphoma: In an ALK-positive lymphoma mouse model, DNA vaccines with plasmids encoding part of the ALK cytoplasmic domain effectively prevented the development of systemic and local lymphoma via specific CD8+T-cell cytotoxicity and interferon-γ response.